Hostname: page-component-586b7cd67f-dsjbd Total loading time: 0 Render date: 2024-11-22T21:30:29.572Z Has data issue: false hasContentIssue false
  • English
  • Français

Treatment of psychosis during pregnancy – a case report and a mini-review

Published online by Cambridge University Press:  24 June 2014

René E. Nielsen
René E. Nielsen*
Affiliation:
Unit for Psychiatric Research, Aalborg Psychiatric Hospital, Aarhus University Hospital, Aalborg, Denmark
*
René Ernst Nielsen, Unit for Psychiatric Research, Aalborg Psychiatric Hospital, Aarhus University Hospital, Mølleparkvej 10, 9000 Aalborg, Denmark. Tel: +45 28 72 29 62; Fax: +45 72 13 72 35; E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Extract

Nielsen RE. Treatment of psychosis during pregnancy – a case report and a mini-review.

Objective: Describe clinical problems in treating a patient with psychotic symptoms during pregnancy by presenting a case report, and review the current evidence on antipsychotic drugs during pregnancy.

Methods: The review consists of a non-systematic clinical review of current data on treatment with antipsychotics during pregnancy. The case, a 27 year old female initially diagnosed with posttraumatic stress disorder (PTSD) after a rape and emotionally unstable personality disorder, illustrates some of the common challenges a clinician meets. The patient initially discontinues all treatment as she is unsure if the drugs could have a teratogenic effect and is changed to a treatment that is regarded as safe during pregnancy.

Results: The current data supports treatment with chlorpromazine although there is a risk of side effects, e.g. extrapyramidal symptoms and hypotension, but also treatment with olanzapine and risperidone. If the patient is currently treated with clozapine, this treatment should be continued, due to clozapines unique efficacy profile. Blood monitoring for six months after birth is recommended when the newborn has been exposed to clozapine treatment.

Conclusion: Current evidence on treatment with antipsychotics during pregnancy is sparse, but not treating is associated with increased risks compared to treatment.

Keywords

antipsychoticsmalformationneonatal withdrawal syndromepregnancy
Type
Review Article
Information
Acta Neuropsychiatrica , Volume 23 , Issue 5 , October 2011 , pp. 210 - 214
Copyright
Copyright © Cambridge University Press 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Gentile, S. Antipsychotic therapy during early and late pregnancy. A systematic review. Schizophr Bull 2010;36: 518–544. CrossRefGoogle ScholarPubMed
2. Grover, S, Avasthi, A, Sharma, Y. Psychotropics in pregnancy: weighing the risks. Indian J Med Res 2006;123:497–512. Google ScholarPubMed
3. Webb, RT, Howard, L, Abel, KM. Antipsychotic drugs for non-affective psychosis during pregnancy and postpartum. Cochrane Database Syst Rev 2004;CD004411. DOI: 10.1002/14651858.CD004411.pub2.Google ScholarPubMed
4. Cox, JL, Holden, JM, Sagovsky, R. Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry 1987;150: 782–786. CrossRefGoogle ScholarPubMed
5. Gentile, S. On categorizing gestational, birth, and neonatal complications following late pregnancy exposure to antidepressants: the prenatal antidepressant exposure syndrome. CNS Spectr 2010;15:167–185. CrossRefGoogle ScholarPubMed
6. Einarson, A, Boskovic, R. Use and safety of antipsychotic drugs during pregnancy. J Psychiatr Pract 2009;15: 183–192. CrossRefGoogle ScholarPubMed
7. Miller, LJ, Finnerty, M. Sexuality pregnancy, and childrearing among women with schizophrenia-spectrum disorders. Psychiatr Serv 1996;47:502–506. Google ScholarPubMed
8. Coverdale, JH, Bayer, TL, Mccullough, LB, Chervenak, FA. Respecting the autonomy of chronic mentally ill women in decisions about contraception. Hosp Community Psychiatry 1993;44:671–674. Google ScholarPubMed
9. Gavin, NI, Gaynes, BN, Lohr, KN, Meltzer-Brody, S, Gartlehner, G, Swinson, T. Perinatal depression: a systematic review of prevalence and incidence. Obstet Gynecol 2005;106:1071–1083. CrossRefGoogle ScholarPubMed
10. Casiano, ME, Hawkins, DR. Major mental illness and childbearing. A role for the consultation-liaison psychiatrist in obstetrics. Psychiatr Clin North Am 1987;10:35–51. CrossRefGoogle ScholarPubMed
11. Desai, G, Chandra, PS. Ethical issues in treating pregnant women with severe mental illness. Indian J Med Ethics 2009;6:75–77. Google ScholarPubMed
12. Lutz, UC, Hiemke, C, Wiatr, G, Farger, G, Arand, J, Wildgruber, D. Aripiprazole in pregnancy and lactation: a case report. J Clin Psychopharmacol 2010;30:204–205. CrossRefGoogle ScholarPubMed
13. Mendhekar, DN, Sharma, JB, Srilakshmi, P. Use of aripiprazole during late pregnancy in a woman with psychotic illness. Ann Pharmacother 2006;40:575. CrossRefGoogle Scholar
14. Mendhekar, DN, Sunder, KR, Andrade, C. Aripiprazole use in a pregnant schizoaffective woman. Bipolar Disord 2006;8:299–300. CrossRefGoogle Scholar
15. Mervak, B, Collins, J, Valenstein, M. Case report of aripiprazole usage during pregnancy. Arch Womens Ment Health 2008;11:249–250. CrossRefGoogle ScholarPubMed
16. Coppola, D, Russo, LJ, Kwarta, RF Jr, Varughese, R, Schmider, J. Evaluating the postmarketing experience of risperidone use during pregnancy: pregnancy and neonatal outcomes. Drug Saf 2007;30:247–264. CrossRefGoogle ScholarPubMed
17. Arora, M, Praharaj, SK. Meningocele and ankyloblepharon following in utero exposure to olanzapine. Eur Psychiatry 2006;21:345–346. CrossRefGoogle ScholarPubMed
18. Janusinfo, Medical Knowledge Center. Stockholms Läns Landsting 2010; http://www.janusinfo.se/gravreg/.Google Scholar
19. Pinkofsky, HB, Fitz-Gerald, MJ, Reeves, RR. Psychotropic treatment during pregnancy. Am J Psychiatry 1997;154:718–719. Google ScholarPubMed
20. Lin, HC, Chen, IJ, Chen, YH, Lee, HC, Wu, FJ. Maternal schizophrenia and pregnancy outcome: does the use of antipsychotics make a difference? Schizophr Res 2010;116: 55–60. CrossRefGoogle Scholar
21. Matevosyan, NR. Pregnancy and postpartum specifics in women with schizophrenia: a meta-study. Arch Gynecol Obstet 2011;283:141–147. CrossRefGoogle ScholarPubMed
22. Reis, M, Kallen, B. Maternal use of antipsychotics in early pregnancy and delivery outcome. J Clin Psychopharmacol 2008;28:279–288. CrossRefGoogle ScholarPubMed
23. Mckenna, K, Koren, G, Tetelbaum, M et al. Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study. J Clin Psychiatry 2005;66: 444–449. CrossRefGoogle ScholarPubMed
24. Newham, JJ, Thomas, SH, Macritchie, K, Mcelhatton, PR, Mcallister-Williams, RH. Birth weight of infants after maternal exposure to typical and atypical antipsychotics: prospective comparison study. Br J Psychiatry 2008;192:333–337. CrossRefGoogle ScholarPubMed
25. Kahn, RS, Fleischhacker, WW, Boter, H et al. Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. Lancet 2008;371:1085–1097. CrossRefGoogle ScholarPubMed
26. Lieberman, JA, Stroup, TS, Mcevoy, JP et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005;353:1209–1223. CrossRefGoogle ScholarPubMed
27. Diav-Citrin, O, Shechtman, S, Ornoy, S et al. Safety of haloperidol and penfluridol in pregnancy: a multicenter, prospective, controlled study. J Clin Psychiatry 2005;66: 317–322. CrossRefGoogle ScholarPubMed
28. Kris, EB, Carmichael, DM. Chlorpromazine maintenance therapy during pregnancy and confinement. Psychiatr Q 1957;31:690–695. CrossRefGoogle ScholarPubMed
29. Kris, EB. Children of mothers maintained on pharmacotherapy during pregnancy and postpartum. Curr Ther Res Clin Exp 1965;7:785–789. Google ScholarPubMed
30. Sobel, DE. Fetal damage due to ECT, insulin coma, chlorpromazine, or reserpine. Arch Gen Psychiatry 1960;2: 606–611. CrossRefGoogle ScholarPubMed
31. Tamer, A, Mckey, R, Arias, D, Worley, L, Fogel, BJ. Phenothiazine-induced extrapyramidal dysfunction in the neonate. J Pediatr 1969;75:479–480. CrossRefGoogle ScholarPubMed
32. Levy, W, Wisniewski, K. Chlorpromazine causing extrapyramidal dysfunction in newborn infant of psychotic mother. N Y State J Med 1974;74:684–685. Google ScholarPubMed
33. Hill, RM, Desmond, MM, Kay, JL. Extrapyramidal dysfunction in an infant of a schizophrenic mother. J Pediatr 1966;69:589–595. CrossRefGoogle Scholar
34. Gentile, S. Neurodevelopmental effects of prenatal exposure to psychotropic medications. Depress Anxiety 2010;27: 675–686. CrossRefGoogle ScholarPubMed
35. Slone, D, Siskind, V, Heinonen, OP, Monson, RR, Kaufman, DW, Shapiro, S. Antenatal exposure to the phenothiazines in relation to congenital malformations, perinatal mortality rate, birth weight, and intelligence quotient score. Am J Obstet Gynecol 1977;128:486–488. CrossRefGoogle Scholar
36. Stika, L, Elisova, K, Honzakova, L et al. Effects of drug administration in pregnancy on children's school behaviour. Pharm Weekbl Sci 1990;12:252–255. Google ScholarPubMed